Low physical activity and obesity: Causes of chronic disease or simply predictors?

Medicine and Science in Sports and Exercise

Volumn 39, Issue 8, 2007, Pages 1233-1240

  Telford, Richard D ^a,b,c  

^a AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

^b NATIONAL HEALTH AND MEDICAL RESEARCH COUNCIL   (Australia)

^c Canberra Hospital   (Australia)

Author keywords

Cardiovascular disease; Cytokines; Exercise; Fitness; Prevention; Risk factors

Indexed keywords

CYTOKINE;

BODY FAT; CARDIOVASCULAR DISEASE; CHRONIC DISEASE; DISEASE ASSOCIATION; DISEASE MARKER; EXERCISE; FITNESS; HUMAN; INSULIN RELEASE; INSULIN RESISTANCE; METABOLIC DISORDER; MORBIDITY; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PHYSICAL ACTIVITY; PREDICTOR VARIABLE; REVIEW; RISK ASSESSMENT; RISK FACTOR;

ADIPOSITY; AUSTRALIAN CAPITAL TERRITORY; CARDIOVASCULAR DISEASES; CAUSALITY; CHRONIC DISEASE; CYTOKINES; DIABETES MELLITUS, TYPE 2; EXERCISE; HUMANS; INSULIN RESISTANCE; METABOLIC DISEASES; OBESITY; RISK FACTORS;

EID: 34548295180     PISSN: 01959131     EISSN: 15300315     Source Type: Journal    
DOI: 10.1249/mss.0b013e31806215b7     Document Type: Review

References (73)

1. ALLEN, D. L., B. C. HARRISON, A. MAASS, M. L. BELL, W. C. BYRNES, and L. A. LEINWAND. Cardiac and skeletal muscle adaptations to voluntary wheel running in the mouse. J. Appl. Physiol. 90:1900-1908, 2001.
2. ANDERSEN, L. B., S. A. ANDERSSEN, and B. SALTIN. Letter regarding article by Christou et al, "Fatness is a better predictor of cardiovascular disease risk factor profile than aerobic fitness in healthy men". Circulation 112:e253, 2005.
3. BASTARD, J. P., M. MAACHI, C. LAGATHU, et al. Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur. Cytokine Netw. 17:4-12, 2006.
4. BIGAARD, J., K. FREDERIKSEN, A. TJONNELAND, et al. Waist circumference and body composition in relation to all-cause mortality in middle-aged men and women. Int. J. Obes. (Lond.) 29:778-784, 2005.
5. BLAIR, S. N., and T. S. CHURCH. The fitness, obesity, and health equation: is physical activity the common denominator? JAMA 292:1232-1234, 2004.
6. BLAIR, S. N., and W. L. HASKELL. Objectively measured physical activity and mortality in older adults. JAMA 296:216-218, 2006.
7. BLAIR, S. N., and M. J. LAMONTE. Commentary: current perspectives on obesity and health: black and white, or shades of grey? Int. J. Epidemiol. 35:69-72, 2006.
8. BLUHER, M., J. W. BULLEN JR., J. H. LEE, et al. Circulating adiponectin and expression of adiponectin receptors in human skeletal muscle: associations with metabolic parameters and insulin resistance and regulation by physical training. J. Clin. Endocrinol. Metab. 91:2310-2316, 2006.
9. BOOTH, F. W., M. V. CHAKRAVARTHY, S. E. GORDON, and E. E. SPANGENBURG. Waging war on physical inactivity: using modern molecular ammunition against an ancient enemy. J. Appl. Physiol. 93:3-30, 2002.
10. CAMPOS, P., A. SAGUY, P. ERNSBERGER, E. OLIVER, and G. GAESSER. The epidemiology of overweight and obesity: public health crisis or moral panic? Int. J. Epidemiol. 35:55-60, 2006.
11. CHRISTOU, D. D., C. L. GENTILE, C. A. DESOUZA, D. R. SEALS, and P. E. GATES. Fatness is a better predictor of cardiovascular disease risk factor profile than aerobic fitness in healthy men. Circulation 111:1904-1914, 2005.
12. CHURCH, T. S., M. J. LAMONTE, C. E. BARLOW, and S. N. BLAIR. Cardiorespiratory fitness and body mass index as predictors of cardiovascular disease mortality among men with diabetes. Arch. Intern. Med. 165:2114-2120, 2005.
13. COLBERG, S. R., J. A. SIMONEAU, F. L. THAETE, and D. E. KELLEY. Skeletal muscle utilization of free fatty acids in women with visceral obesity. J. Clin. Invest. 95:1846-1853, 1995.
14. DAHLMAN, I., M. FORSGREN, A. SJOGREN, et al. Downregulation of electron transport chain genes in visceral adipose tissue in type 2 diabetes independent of obesity and possibly involving tumor necrosis factor-{alpha}. Diabetes 55:1792-1799, 2006.
15. DAYER, J. M., R. CHICHEPORTICHE, C. JUGE-AUBRY, and C. MEIER. Adipose tissue has anti-inflammatory properties: focus on IL-1 receptor antagonist (IL-1Ra). Ann. N. Y. Acad. Sci. 1069:444-453, 2006.
16. DEFRONZO, R. A., R. GUNNARSSON, O. BJORKMAN, M. OLSSON, and J. WAHREN. Effects of insulin on peripheral and splanchnic glucose metabolism in noninsulin-dependent (type II) diabetes mellitus. J. Clin. Invest. 76:149-155, 1985.
17. ERIKSSON, K. F., and F. LINDGARDE. No excess 12-year mortality in men with impaired glucose tolerance who participated in the Malmo Preventive Trial with diet and exercise. Diabetologia 41:1010-1016, 1998.
18. FANG, J., J. WYLIE-ROSETT, H. W. COHEN, R. C. KAPLAN, and M. H. ALDERMAN. Exercise, body mass index, caloric intake, and cardiovascular mortality. Am. J. Prev. Med. 25:283-289, 2003.
19. FANTUZZI, G. Adipose tissue, adipokines, and inflammation. J. Allergy Clin. Immunol. 115:911-919, 2005.
20. FARRELL, S. W., L. BRAUN, C. E. BARLOW, Y. J. CHENG, and S. N. BLAIR. The relation of body mass index, cardiorespiratory fitness, and all-cause mortality in women. Obes. Res. 10:417-423, 2002.
21. FRANKS, P. W., S. BRAGE, J. LUAN, et al. Leptin predicts a worsening of the features of the metabolic syndrome independently of obesity. Obes. Res. 13:1476-1484, 2005.
22. FRAYN, K. N. Adipose tissue as a buffer for daily lipid flux. Diabetologia 45:1201-1210, 2002.
23. FRUEBIS, J., T. S. TSAO, S. JAVORSCHI, et al. Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc. Natl. Acad. Sci. U. S. A. 98:2005-2010, 2001.
24. FUKAI, T., M. R. SIEGFRIED, M. USHIO-FUKAI, Y. CHENG, G. KOJDA, and D. G. HARRISON. Regulation of the vascular extracellular superoxide dismutase by nitric oxide and exercise training. J. Clin. Invest. 105:1631-1639, 2000.
25. GU, D., J. HE, X. DUAN, et al. Body weight and mortality among men and women in China. JAMA 295:776-783, 2006.
26. HAWLEY, J. A. Exercise as a therapeutic intervention for the prevention and treatment of insulin resistance. Diabetes Metab. Res. Rev. 20:383-393, 2004.
27. HU, G., T. J. SILVENTOINEN, K. BARENGO, and N. JOUSILAHTI. Joint effects of physical activity, body mass index, waist circumference and waist-to-hip ratio with the risk of cardiovascular disease among middle-aged Finnish men and women. Eur. Heart J. 25:2212-2219, 2004.
28. ITO, Y., S. NOMURA, H. UEDA, et al. Exercise training increases membrane bound form of tumor necrosis factor-alpha receptors with decreases in the secretion of soluble forms of receptors in rat adipocytes. Life Sci. 71:601-609, 2002.
29. JENSEN, M. D. Is visceral fat involved in the pathogenesis of the metabolic syndrome? Human model. Obesity (Silver Spring) 14(Suppl 1):20S-24S, 2006.
30. KARJALAINEN, J., H. TIKKANEN, M. HERNELAHTI, and U. M. KUJALA. Muscle fiber-type distribution predicts weight gain and unfavorable left ventricular geometry: a 19 year follow-up study. BMC Cardiovasc. Disord. 6:2, 2006.
31. KATZMARZYK, P. T., T. S. CHURCH, I. JANSSEN, R. ROSS, and S. N. BLAIR. Metabolic syndrome, obesity, and mortality: impact of cardiorespiratory fitness. Diabetes Care 28:391-397, 2005.
32. KELLEY, D. E. Skeletal muscle fat oxidation: timing and flexibility are everything. J. Clin. Invest. 115:1699-1702, 2005.
33. KERN, P. A., G. B. DI GREGORIO, T. LU, N. RASSOULI, and G. RANGANATHAN. Adiponectin expression from human adipose tissue: relation to obesity, insulin resistance, and tumor necrosis factor-alpha expression. Diabetes 52:1779-1785, 2003.
34. KINGWELL, B. A. Nitric oxide-mediated metabolic regulation during exercise: effects of training in health and cardiovascular disease. FASEB J. 14:1685-1696, 2000.
35. KLEIN, S., L. FONTANA, V. L. YOUNG, et al. Absence of an effect of liposuction on insulin action and risk factors for coronary heart disease. N. Engl. J Med. 350:2549-2557, 2004.
36. KRISKA, A. M., M. A. PEREIRA, R. L. HANSON, et al. Association of physical activity and serum insulin concentrations in two populations at high risk for type 2 diabetes but differing by BMI. Diabetes Care 24:1175-1180, 2001.
37. KUJALA, U. M., S. SARNA, J. KAPRIO, H. O. TIKKANEN, and M. KOSKENVUO. Natural selection to sports, later physical activity habits, and coronary heart disease. Br. J. Sports Med. 34:445-449, 2000.
38. KUK, J. L., P. T. KATZMARZYK, M. Z. NICHAMAN, T. S. CHURCH, S. N. BLAIR, and R. ROSS. Visceral fat is an independent predictor of all-cause mortality in men. Obesity (Silver Spring) 14:336-341, 2006.
39. LARSON-MEYER, D. E., L. K. HEILBRONN, L. M. REDMAN, et al. Effect of calorie restriction with or without exercise on insulin sensitivity, beta-cell function, fat cell size, and ectopic lipid in overweight subjects. Diabetes Care 29:1337-1344, 2006.
40. LEE, C. D., S. N. BLAIR, and A. S. JACKSON. Cardiorespiratory fitness, body composition, and all-cause and cardiovascular disease mortality in men. Am. J. Clin. Nutr. 69:373-380, 1999.
41. LEE, Y., M. Y. WANG, T. KAKUMA, et al. Liporegulation in diet-induced obesity. The antisteatotic role of hyperleptinemia. J. Biol. Chem. 276:5629-5635, 2001.
42. LI, T. Y., J. S. RANA, J. E. MANSON, et al. Obesity as compared with physical activity in predicting risk of coronary heart disease in women. Circulation 113:499-506, 2006.
43. LÓPEZ-SORIANO, J., C. CHIELLINI, M. MAFFEI, P. A. GRIMALDI, and J. M. ARGILES. Roles of skeletal muscle and peroxisome proliferator-activated receptors in the development and treatment of obesity. Endocr. Rev. 27:318-329, 2006.
44. MANINI, T. M., J. E. EVERHART, K. V. PATEL, et al. Daily activity energy expenditure and mortality among older adults. JAMA 296:171-179, 2006.
45. MANSON, J. E., P. GREENLAND, A. Z. LACROIX, et al. Walking compared with vigorous exercise for the prevention of cardiovascular events in women. N. Engl. J Med. 347:716-725, 2002.
46. MASAKI, T., S. CHIBA, T. YASUDA, et al. Peripheral, but not central, administration of adiponectin reduces visceral adiposity and upregulates the expression of uncoupling protein in agouti yellow (Ay/a) obese mice. Diabetes 52:2266-2273, 2003.
47. NICKLAS, B. J., T. YOU, and M. PAHOR. Behavioural treatments for chronic systemic inflammation: effects of dietary weight loss and exercise training. CMAJ 172:1199-1209, 2005.
48. PAFFENBARGER, R. S., JR., S. N. BLAIR, I. M. LEE, and R. T. HYDE. Measurement of physical activity to assess health effects in freeliving populations. Med. Sci. Sports Exerc. 25:60-70, 1993.
49. PEDERSEN, B. K., and B. SALTIN. Evidence for prescribing exercise as therapy in chronic disease. Scand. J. Med. Sci. Sports 16(Suppl 1):3-63, 2006.
50. PEDERSEN, B. K., A. STEENSBERG, P. KELLER, et al. Muscle-derived interleukin-6: lipolytic, anti-inflammatory and immune regulatory effects. Pflugers Arch. 446:9-16, 2003.
51. PELLME, F., U. SMITH, T. FUNAHASHI, et al. Circulating adiponectin levels are reduced in nonobese but insulin-resistant first-degree relatives of type 2 diabetic patients. Diabetes 52:1182-1186, 2003.
52. PETERSEN, A. M., and B. K. PEDERSEN. The anti-inflammatory effect of exercise. J. Appl. Physiol. 98:1154-1162, 2005.
53. RAZ, I., R. ELDOR, S. CERNEA, and E. SHAFRIR. Diabetes: insulin resistance and derangements in lipid metabolism. Cure through intervention in fat transport and storage. Diabetes Metab. Res. Rev. 21:3-14, 2005.
54. ROMERO-CORRAL, A., V. M. MONTORI, V. K. SOMERS, et al. Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies. Lancet 368:666-678, 2006.
55. ROSS, R., I. JANSSEN, J. DAWSON, et al. Exercise-induced reduction in obesity and insulin resistance in women: a randomized controlled trial. Obes. Res. 12:789-798, 2004.
56. SHEPHERD, P. R., and B. B. KAHN. Glucose transporters and insulin action - implications for insulin resistance and diabetes mellitus. N. Engl. J. Med. 341:248-257, 1999.
57. SNIJDER, M. B., R. M. VAN DAM, M. VISSER, and J. C. SEIDELL. What aspects of body fat are particularly hazardous and how do we measure them? Int. J. Epidemiol. 35:83-92, 2006.
58. STALLKNECHT, B., J. J. LARSEN, K. J. MIKINES, L. SIMONSEN, J. BULOW, and H. GALBO. Effect of training on insulin sensitivity of glucose uptake and lipolysis in human adipose tissue. Am. J. Physiol. Endocrinol. Metab. 279:E376-E385, 2000.
59. STEINBERG, G. R., M. L. PAROLIN, G. J. HEIGENHAUSER, and D. J. DYCK. Leptin increases FA oxidation in lean but not obese human skeletal muscle: evidence of peripheral leptin resistance. Am. J. Physiol. Endocrinol. Metab. 283:E187-E192, 2002.
60. STEVENS, J., J. CAI, K. R. EVENSON, and R. THOMAS. Fitness and fatness as predictors of mortality from all causes and from cardiovascular disease in men and women in the lipid research clinics study. Am. J. Epidemiol. 156:832-841, 2002.
61. STORLIEN, L., N. D. OAKES, and D. E. KELLEY. Metabolic flexibility. Proc. Nutr. Soc. 63:363-368, 2004.
62. SUMMERS, L. K. Adipose tissue metabolism, diabetes and vascular disease - lessons from in vivo studies. Diab. Vasc. Dis. Res. 3:12-21, 2006.
63. TANASESCU, M., M. F. LEITZMANN, E. B. RIMM, W. C. WILLETT, M. J. STAMPFER, and F. B. HU. Exercise type and intensity in relation to coronary heart disease in men. JAMA 288:1994-2000, 2002.
64. TCHERNOF, A., C. BELANGER, A. S. MORISSET, et al. Regional differences in adipose tissue metabolism in women: minor effect of obesity and body fat distribution. Diabetes 55:1353-1360, 2006.
65. UKROPCOVA, B., M. MCNEIL, O. SEREDA, et al. Dynamic changes in fat oxidation in human primary myocytes mirror metabolic characteristics of the donor. J. Clin. Invest. 115:1934-1941, 2005.
66. WAHRENBERG, H., H. K. HERTEL, B. M. LEIJONHUFVUD, L. G. PERSSON, E. TOFT, and P. AMER. Use of waist circumference to predict insulin resistance: retrospective study. BMJ 330:1363-1364, 2005.
67. WANNAMETHEE, S. G., A. G. SHAPER, and K. G. ALBERTI. Physical activity, metabolic factors, and the incidence of coronary heart disease and type 2 diabetes. Arch. Intern. Med. 160:2108-2116, 2000.
68. WARNE, J. P. Tumour necrosis factor alpha: a key regulator of adipose tissue mass. J. Endocrinol. 177:351-355, 2003.
69. WEINSTEIN, A. R., and H. D. SESSO. Joint effects of physical activity and body weight on diabetes and cardiovascular disease. Exerc. Sport Sci. Rev. 34:10-15, 2006.
70. WEINSTEIN, A. R., H. D. SESSO, I. M. LEE, et al. Relationship of physical activity vs body mass index with type 2 diabetes in women. JAMA 292:1188-1194, 2004.
71. WEYER, C., J. K. WOLFORD, R. L. HANSON, et al. Subcutaneous abdominal adipocyte size, a predictor of type 2 diabetes, is linked to chromosome 1q21-q23 and is associated with a common polymorphism in LMNA in Pima Indians. Mol. Genet. Metab. 72:231-238, 2001.
72. WILLIAMS, P. T. Physical fitness and activity as separate heart disease risk factors: a meta-analysis. Med. Sci. Sports Exerc. 33:754-761, 2001.
73. ZURLO, F., S. LILLIOJA, A. ESPOSITO-D EL PUENTE, et al. Low ratio of fat to carbohydrate oxidation as predictor of weight gain: study of 24-h RQ. Am. J. Physiol. 259:E650-E657, 1990.